Molecular Mechanisms and Treatment of Rheumatic Diseases

Dear Colleagues,

It gives us great pleasure and excitement to announce the opening of the submission of articles for the Special Issue "Molecular Mechanisms and Treatment of Rheumatic Diseases". Since the beginning of the 2000s, we have been witnessing a revolution in the therapeutic approach to rheumatological diseases both in terms of the standardization of the treatment with the appearance and regular updating of treatment guidelines, as well as the monitoring modality and the established therapeutic targets. This was possible due to an increasingly deeper understanding of the molecular mechanisms underlying the occurrence of these diseases. However, despite the absolute advance of knowledge, there are still many gray areas and unfulfilled needs. Our goal is to stimulate research and clinical interest in this field, which, due to its complexity, lends itself so much to a multidisciplinary approach. This is the reason why we hope that we will be able to publish original articles with an impact on the prognosis of rheumatic patients.

We welcome the submission of original research and review articles on the following topics:

• Diagnostic tools;
• Clinical and immunological correlations;
• Therapeutic challenges;
• Risk stratification;
• Achieving goals in management and treatment;
• Old and new therapeutic targets;
• Comorbidities (diagnosis, correlations, and management).

Prof. Dr. Ruxandra Ionescu
Dr. Daniela Opris-Belinski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• rheumatology
• immune-mediated rheumatic diseases
• biologics
• DMARDs
• arthritis
• lupus
• vasculitis
• spondyloarthritis
• targets